Scientists successfully predicted the thermal expansion of metastable liquid metals by analyzing atomic structures with just one thousand atoms. This breakthrough reveals a connection between microscopic information and macroscopic material properties.
A phase two study demonstrated that a combination of azacitidine and lenalidomide is an effective frontline treatment regimen for patients with higher-risk forms of myelodysplastic syndrome and acute myeloid leukemia. The therapy was well tolerated in the study of 88 patients.
Researchers at Mainz University have discovered that a psoriasis medication may be effective in treating Alzheimer's disease by stimulating the activity of the enzyme ADAM10, which could lead to reduced accumulation of Alzheimer's plaques. The medication was well-tolerated and showed promise in enhancing learning and memory capacity.
A study at Dana-Farber Cancer Institute found that a narrow subset of myeloma cells is responsible for metastasis. The researchers identified 11 genes with functional roles in metastasis and proposed these as potential targets for therapies.
Researchers have discovered novel combinations of targeted therapies and chemotherapy regimens that improve survival outcomes for patients with historically poor-prognosis leukemia. These findings, presented at the American Society of Hematology Annual Meeting, offer new hope for elderly and aggressive genetic mutation patients.
A phase three study has demonstrated increased survival rates among AML patients who relapse, with combination therapy employing cytarabine and vosaroxin showing significant benefits. Patients over 60 years old experienced the greatest overall survival benefit from the treatment.
A phase 2 multicenter trial of ABT-199 found encouraging results in patients with relapsed or resistant acute myelogenous leukemia, with five patients achieving eradication and several more experiencing stable disease. The oral inhibitor targets the BCL-2 protein, which is linked to resistance and poor prognosis in AML patients.
A recent clinical trial found that young adults with acute lymphoblastic leukemia (ALL) who received high-intensity pediatric protocols had better overall survival rates, with 78% achieving overall survival and 66% maintaining event-free survival. This is a significant improvement over previous studies for this age range.
Researchers report successful stem cell transplants in patients with dyskeratosis congenita using immunosuppressive drugs only, avoiding radiation and conventional chemotherapy. All four participants are alive and well after transplant, with no significant toxicities or infections.
In an early-phase clinical trial, a new type of cancer therapy targeting the IDH2 gene produced dramatic results in patients with advanced leukemia. The study found that AG-221 blocked the mutated protein, allowing immature white blood cells to develop normally and leading to complete or partial remissions.
Researchers investigated GaN-based LED structure irradiation with protons and found increased resistance in p-type GaN layers compared to n-type. The observed increase is attributed to lower initial carrier density in p-type GaN, resulting from inadequate doping technology.
UNSW researchers have successfully converted over 40% of sunlight into electricity, exceeding previous records. The breakthrough is made possible by a custom optical bandpass filter that captures wasted sunlight and converts it at a higher efficiency than commercial solar cells.
The latest trial results show a response rate of over 90% among pediatric acute lymphoblastic leukemia patients, with complete responses in 92% and remission rates of 70%. The therapy also demonstrates promise for non-Hodgkin lymphomas, including a 100% response rate in follicular lymphoma patients.
Researchers have identified a gene associated with familial glioma, suggesting that certain individuals may be genetically predisposed to the disease. The POT1 gene mutation is linked to lower-grade oligodendroglioma, which is more sensitive to radiation therapy, and raises hopes for improved treatments and preventive strategies.